Tarsus Pharmaceuticals (TARS) Cost of Revenue (2021 - 2026)
Tarsus Pharmaceuticals (TARS) reported Cost of Revenue of $12.11 million for Q2 2026, up 94.2% from $6.24 million a year earlier and up 28.9% from the prior quarter.
Tarsus Pharmaceuticals (TARS) Cost of Revenue (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Tarsus Pharmaceuticals' Cost of Revenue came in at $40.75 million, up 107.7% year-over-year; for FY2025, it was $30.68 million, up 139.2% from FY2024.
- Cost of Revenue has increased for three consecutive years, with a four-year compound annual growth rate of 96.1% (FY2021 to FY2025).
- By year, Cost of Revenue came in at $12.83 million in FY2024 (+705.1%), $1.59 million in FY2023 (+66.8%), $955,000 in FY2022 (-54.0%) and $2.08 million in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Cost of Revenue in data going back to Q1 2021.
- Year over year, Cost of Revenue has now increased in each of the last eight quarters, with growth averaging 230.0% over the last eight quarters.
- The high point for year-over-year Cost of Revenue in five years was Q3 2024 (growth of 759.9%); the low point was Q1 2022 (a decline of 97.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $9.4 million (Q1 2026), $10.93 million (Q4 2025) and $8.31 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Tarsus Pharmaceuticals | 3.16 Bn | 2.10 Bn | 161.80 Mn | 12.11 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.11 Mn |
| Mar 31, 2026 | 9.40 Mn |
| Dec 31, 2025 | 10.93 Mn |
| Sep 30, 2025 | 8.31 Mn |
| Jun 30, 2025 | 6.24 Mn |
| Mar 31, 2025 | 5.21 Mn |
| Dec 31, 2024 | 4.93 Mn |
| Sep 30, 2024 | 3.24 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 1.65 Mn |
| Dec 31, 2023 | 1.22 Mn |
| Sep 30, 2023 | 377,000.00 |
| Dec 31, 2022 | 400,000.00 |
| Jun 30, 2022 | 522,000.00 |
| Mar 31, 2022 | 33,000.00 |
| Dec 31, 2021 | -24,000.00 |
| Sep 30, 2021 | 65,000.00 |
| Jun 30, 2021 | 737,000.00 |
| Mar 31, 2021 | 1.30 Mn |
Tarsus Pharmaceuticals Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TARS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();